{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:29:32Z","timestamp":1787502572228,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI116441-03"],"award-info":[{"award-number":["5R01AI116441-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00436-017-5593-9","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T03:52:04Z","timestamp":1503287524000},"page":"2821-2830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis"],"prefix":"10.1007","volume":"116","author":[{"given":"Nikhil","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyankana","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal K.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Canciamille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-9245","authenticated-orcid":false,"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"5593_CR1","doi-asserted-by":"publisher","unstructured":"Abraham D, Grieve RB, Holy JM, Christensen BM (1989) Immunity to larval Brugia malayi in BALB\/c mice: protective immunity and inhibition of larval development. Am J Trop Med Hyg 40:598\u2013604.https:\/\/doi.org\/10.4269\/ajtmh.1989.40.598","DOI":"10.4269\/ajtmh.1989.40.598"},{"key":"5593_CR2","doi-asserted-by":"publisher","unstructured":"Anand SB, Murugan V, Prabhu PR, Anandharaman V, Reddy MV, Kaliraj P (2008) Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Acta Trop 107:106\u2013112.https:\/\/doi.org\/10.1016\/j.actatropica.2008.04.018","DOI":"10.1016\/j.actatropica.2008.04.018"},{"key":"5593_CR3","doi-asserted-by":"publisher","unstructured":"Arias MA, Van Roey GA, Tregoning JS, Moutaftsi M, Coler RN, Windish HP, Reed SG, Carter D, Shattock RJ (2012) Glucopyranosyl lipid adjuvant (GLA), a synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. PLoS One 7:e41144.https:\/\/doi.org\/10.1371\/journal.pone.0041144","DOI":"10.1371\/journal.pone.0041144"},{"key":"5593_CR4","doi-asserted-by":"publisher","unstructured":"Arumugam S, Wei J, Ward D, Abraham D, Lustigman S, Zhan B, Klei TR (2014) Vaccination with a genetically modified Brugia malayi cysteine protease inhibitor-2 reduces adult parasite numbers and affects the fertility of female worms following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae. Int J Parasitol 44:675\u2013679.https:\/\/doi.org\/10.1016\/j.ijpara.2014.05.003","DOI":"10.1016\/j.ijpara.2014.05.003"},{"key":"5593_CR5","doi-asserted-by":"publisher","unstructured":"Bortolatto J1, Borducchi E, Rodriguez D, Keller AC, Faquim-Mauro E, Bortoluci KR, Mucida D, Gomes E, Christ A, Schnyder-Candrian S, Schnyder B, Ryffel B, Russo M (2008) Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12\/interferon-gamma axis. Clin Exp Allergy 38:1668\u20131679.https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03036.x","DOI":"10.1111\/j.1365-2222.2008.03036.x"},{"key":"5593_CR6","doi-asserted-by":"publisher","unstructured":"Carroll EC, Jin L, Mori A, Mu\u00f1oz-Wolf N, Oleszycka E, Moran HB, Mansouri S, McEntee CP, Lambe E, Agger EM, Andersen P, Cunningham C, Hertzog P, Fitzgerald KA, Bowie AG, Lavelle EC (2016) The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons. Immunity 44:597\u2013608.https:\/\/doi.org\/10.1016\/j.immuni.2016.02.004","DOI":"10.1016\/j.immuni.2016.02.004"},{"key":"5593_CR7","doi-asserted-by":"publisher","unstructured":"Casella CR, Mitchell TC (2008) Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 65:3231\u20133240.https:\/\/doi.org\/10.1007\/s00018-008-8228-6 Review","DOI":"10.1007\/s00018-008-8228-6"},{"key":"5593_CR8","doi-asserted-by":"publisher","unstructured":"Coler RN, Bertholet S, Moutaftsi M, Guderian JA, Windish HP, Baldwin SL, Laughlin EM, Duthie MS, Fox CB, Carter D, Friede M, Vedvick TS, Reed SG (2011) Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS One 6:e16333.https:\/\/doi.org\/10.1371\/journal.pone.0016333","DOI":"10.1371\/journal.pone.0016333"},{"key":"5593_CR9","doi-asserted-by":"publisher","unstructured":"Dakshinamoorthy G, Samykutty AK, Munirathinam G, Shinde GB, Nutman T, Reddy MV, Kalyanasundaram R (2012) Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. PLoS One 7:e34077.https:\/\/doi.org\/10.1371\/journal.pone.0034077","DOI":"10.1371\/journal.pone.0034077"},{"key":"5593_CR10","doi-asserted-by":"publisher","unstructured":"Dakshinamoorthy G, Kalyanasundaram R (2013a) Evaluating the efficacy of rBmHATalphac as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation. Vaccine 32:19-25.https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.083","DOI":"10.1016\/j.vaccine.2013.10.083"},{"key":"5593_CR11","doi-asserted-by":"publisher","unstructured":"Dakshinamoorthy G, Munirathinam G, Stoicescu K, Reddy MV, Kalyanasundaram R (2013b) Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis. PLoS One 8:e77394.https:\/\/doi.org\/10.1371\/journal.pone.0077394","DOI":"10.1371\/journal.pone.0077394"},{"key":"5593_CR12","doi-asserted-by":"publisher","unstructured":"Dakshinamoorthy G, Samykutty AK, Munirathinam G, Reddy MV, Kalyanasundaram R (2013c) Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine 31:1616-1622.https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.055","DOI":"10.1016\/j.vaccine.2012.09.055"},{"key":"5593_CR13","doi-asserted-by":"publisher","unstructured":"Dakshinamoorthy G, von Gegerfelt A, Andersen H, Lewis M, Kalyanasundaram R (2014) Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model. PLoS One 9:e112982.https:\/\/doi.org\/10.1371\/journal.pone.0112982 eCollection 2014","DOI":"10.1371\/journal.pone.0112982"},{"key":"5593_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0169-4758(91)90215-A","volume":"7","author":"KP Day","year":"1991","unstructured":"Day KP (1991) The endemic normal in lymphatic filariasis: a static concept. Parasitol Today 7:341\u2013343","journal-title":"Parasitol Today"},{"key":"5593_CR15","doi-asserted-by":"publisher","unstructured":"Di Pasquale A, Preiss S, Tavares Da Silva F, Gar\u00e7on N (2015) Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel) 3:320\u2013343.https:\/\/doi.org\/10.3390\/vaccines3020320 Review","DOI":"10.3390\/vaccines3020320"},{"key":"5593_CR16","doi-asserted-by":"publisher","unstructured":"Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, Larocque D, Van Mechelen M, Gar\u00e7on N (2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 183:6186\u20136197.https:\/\/doi.org\/10.4049\/jimmunol.0901474","DOI":"10.4049\/jimmunol.0901474"},{"key":"5593_CR17","doi-asserted-by":"publisher","unstructured":"Fox CB, Friede M, Reed SG, Ireton GC (2010) Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants. Subcell Biochem 53:303\u2013321.https:\/\/doi.org\/10.1007\/978-90-481-9078-2_14","DOI":"10.1007\/978-90-481-9078-2_14"},{"key":"5593_CR18","doi-asserted-by":"publisher","unstructured":"Gnanasekar M, Rao KV, He YX, Mishra PK, Nutman TB, Kaliraj P, Ramaswamy K (2004) Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun 72:4707\u20134715.https:\/\/doi.org\/10.1128\/IAI.72.8.4707-4715.2004","DOI":"10.1128\/IAI.72.8.4707-4715.2004"},{"key":"5593_CR19","doi-asserted-by":"publisher","unstructured":"Golde WT, Gollobin P, Rodriguez LL (2005) A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Animal 34:39\u201343.https:\/\/doi.org\/10.1038\/laban1005-39","DOI":"10.1038\/laban1005-39"},{"key":"5593_CR20","doi-asserted-by":"publisher","unstructured":"Goulopoulou S, McCarthy CG, Webb RC (2016) Toll-like receptors in the vascular system: sensing the dangers within. Pharmacol Rev 68:142\u2013167.https:\/\/doi.org\/10.1124\/pr.114.010090 Review","DOI":"10.1124\/pr.114.010090"},{"key":"5593_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","volume":"32","author":"RK Gupta","year":"1998","unstructured":"Gupta RK (1998) Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 32:155\u2013172","journal-title":"Adv Drug Deliv Rev"},{"key":"5593_CR22","doi-asserted-by":"publisher","unstructured":"Habets MN, van Selm S, van Opzeeland FJ, Simonetti E, Hermans PW, de Jonge MI, Diavatopoulos DA (2016) Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media. Vaccine 34:5968\u20135974.https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.057","DOI":"10.1016\/j.vaccine.2016.09.057"},{"key":"5593_CR23","doi-asserted-by":"publisher","unstructured":"Harris JR, Wiegand RE (2017) Detecting infection hotspots: modeling the surveillance challenge for elimination of lymphatic filariasis. PLoS Negl Trop Dis 11:e0005610.10.1371\/journalpntd0005610 eCollection 2017 May","DOI":"10.1371\/journalpntd0005610"},{"key":"5593_CR24","doi-asserted-by":"publisher","unstructured":"Jambulingam P, Subramanian S, de Vlas SJ, Vinubala C, Stolk WA (2016) Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators. Parasit Vectors 9:501.https:\/\/doi.org\/10.1186\/s13071-016-1768-y","DOI":"10.1186\/s13071-016-1768-y"},{"key":"5593_CR25","doi-asserted-by":"publisher","unstructured":"Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS (2008) The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 29:1931\u20131939.https:\/\/doi.org\/10.1016\/j.biomaterials.2007.12.025","DOI":"10.1016\/j.biomaterials.2007.12.025"},{"key":"5593_CR26","doi-asserted-by":"publisher","unstructured":"Joseph SK, Ramaswamy K (2013) Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis. Vaccine 31:3320\u20133326.https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.077","DOI":"10.1016\/j.vaccine.2013.05.077"},{"key":"5593_CR27","doi-asserted-by":"publisher","unstructured":"Kalyanasundaram R, Balumuri P (2011) Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds. Res Rep Trop Med 2011:45\u201356.https:\/\/doi.org\/10.2147\/RRTM.S13679","DOI":"10.2147\/RRTM.S13679"},{"key":"5593_CR28","doi-asserted-by":"publisher","unstructured":"Lin Y, Slight SR, Khader SA (2010) Th17 cytokines and vaccine-induced immunity. Semin Immunopathol 32:79\u201390.https:\/\/doi.org\/10.1007\/s00281-009-0191-2","DOI":"10.1007\/s00281-009-0191-2"},{"key":"5593_CR29","doi-asserted-by":"publisher","unstructured":"Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminum. Nat Rev Immunol 9:287\u2013293.https:\/\/doi.org\/10.1038\/nri2510 Review","DOI":"10.1038\/nri2510"},{"key":"5593_CR30","first-page":"779","volume":"138","author":"T Mohan","year":"2013","unstructured":"Mohan T, Verma P, Rao DN (2013) Novel adjuvants & delivery vehicles for vaccines development: a road ahead. Indian J Med Res 138:779\u2013795","journal-title":"Indian J Med Res"},{"key":"5593_CR31","doi-asserted-by":"publisher","unstructured":"Ramaswamy K (2016) Lymphatic filariasis: current status of elimination using chemotherapy and the need for a vaccine. In: Saxena AK (ed) Top Med Chem, 1st edn. Springer International Publishing, Switzerland, pp 1\u201328.https:\/\/doi.org\/10.1007\/7355_2015_5002","DOI":"10.1007\/7355_2015_5002"},{"key":"5593_CR32","doi-asserted-by":"publisher","unstructured":"Samykutty A, Dakshinamoorthy G, Kalyanasundaram R (2010) Multivalent vaccine for lymphatic filariasis. Procedia Vaccinol 3:12\u201318.https:\/\/doi.org\/10.1016\/j.provac.2010.11.003","DOI":"10.1016\/j.provac.2010.11.003"},{"key":"5593_CR33","doi-asserted-by":"publisher","unstructured":"Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2:947\u2013950.https:\/\/doi.org\/10.1038\/ni712","DOI":"10.1038\/ni712"},{"key":"5593_CR34","doi-asserted-by":"crossref","unstructured":"Steinhagen F, Kinjo T, Bode C, Klinman DM (2011) TLR-based immune adjuvants. Vaccine 29:3341\u20133355. https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.002","DOI":"10.1016\/j.vaccine.2010.08.002"},{"key":"5593_CR35","doi-asserted-by":"publisher","unstructured":"Tewari K, Flynn BJ, Boscardin SB, Kastenmueller K, Salazar AM, Anderson CA, Soundarapandian V, Ahumada A, Keler T, Hoffman SL, Nussenzweig MC, Steinman RM, Seder RA (2010) Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and \u03b1DEC-CSP in non human primates. Vaccine 28:7256\u20137266.https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.098","DOI":"10.1016\/j.vaccine.2010.08.098"},{"key":"5593_CR36","doi-asserted-by":"publisher","unstructured":"Thirugnanam S, Pandiaraja P, Ramaswamy K, Murugan V, Gnanasekar M, Nandakumar K, Reddy MV, Kaliraj P (2007) Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Exp Parasitol 116:483\u2013491.https:\/\/doi.org\/10.1016\/j.exppara.2007.02.017","DOI":"10.1016\/j.exppara.2007.02.017"},{"key":"5593_CR37","unstructured":"WHO (2016) Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec 9:441-455"},{"key":"5593_CR38","unstructured":"WHO (2017) http:\/\/www.who.int\/lymphatic_filariasis\/global_progress\/en\/. Accessed 06.09.17"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-017-5593-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-017-5593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-017-5593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:06:47Z","timestamp":1744135607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-017-5593-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["5593"],"URL":"https:\/\/doi.org\/10.1007\/s00436-017-5593-9","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by the National Institutes of Health (NIH), MD, USA (grant number AI-116441).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. Use of animal in this study was approved by the Animal Care Committee of the University of Illinois, Rockford. The study followed the National Institutes of Health guidelines for the care and use of laboratory animals. This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}